Many studies have shown that ovarian cancer cells with p53null mutations (found in SKOV3), which mediate the complete absence of p53 expression and function, exhibit a worse prognosis than other types of p53-expressing mutation harboring ovarian cancers [34]. This evidence concerns the gene TP53 and ovarian cancer.